US Patent Issued to ACCENT THERAPEUTICS on Feb. 25 for "Inhibitors of RNA helicase DHX9 and uses thereof" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,065, issued on Feb. 25, was assigned to ACCENT THERAPEUTICS INC. (Lexington, Mass.).

"Inhibitors of RNA helicase DHX9 and uses thereof" was invented by Matthew H. Daniels (Somerville, Mass.), Kenneth W. Duncan (Westwood, Mass.), Brian Andrew Sparling (Saugus, Mass.), Andrew Stewart Tasker (Simi Valley, Calif.) and Gavin Whitlock (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds of the Formula (IVB):or pharmaceutically acceptable salts thereof, which are useful for the inhibition of DHX9 and in the treatment of a variety of DHX9 mediated conditions or diseases, such as cancer."

The patent was filed on March 28, ...